2-[(1R*,4R*)-4-Aminocyclohexyl]-5-fluoroisoindolin-1-one hydrochloride
|
- $274 - $708
- Product name: 2-[(1R*,4R*)-4-Aminocyclohexyl]-5-fluoroisoindolin-1-one hydrochloride
- CAS: 1707358-57-3
- MF: C14H17FN2O.ClH
- MW: 284.76
- EINECS:
- MDL Number:MFCD26097113
- Synonyms:2-[(1R*,4R*)-4-Aminocyclohexyl]-5-fluoroisoindolin-1-one hydrochloride;2-(4-aminocyclohexyl)-5-fluoro-3H-isoindol-1-one
4 prices
Selected condition:
Brand
- aablocks
- Chemenu
- Crysdot
Package
- 100mg
- 250mg
- 1g
- Manufactureraablocks
- Product numberAA01F4X3
- Product description2-(trans-4-Aminocyclohexyl)-5-fluoroisoindolin-1-one hydrochloride 95%
- Packaging100mg
- Price$274
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01F4X3
- Product description2-(trans-4-Aminocyclohexyl)-5-fluoroisoindolin-1-one hydrochloride 95%
- Packaging250mg
- Price$540
- Updated2026-05-30
- Buy
- ManufacturerChemenu
- Product numberCM261440
- Product description2-(trans-4-Aminocyclohexyl)-5-fluoroisoindolin-1-one hydrochloride 95%+
- Packaging1g
- Price$708
- Updated2026-05-26
- Buy
- ManufacturerCrysdot
- Product numberCD11237652
- Product description2-(trans-4-Aminocyclohexyl)-5-fluoroisoindolin-1-one hydrochloride 97%
- Packaging1g
- Price$705
- Updated2026-05-26
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA01F4X3 | 2-(trans-4-Aminocyclohexyl)-5-fluoroisoindolin-1-one hydrochloride 95% | 100mg | $274 | 2026-05-30 | Buy |
| aablocks | AA01F4X3 | 2-(trans-4-Aminocyclohexyl)-5-fluoroisoindolin-1-one hydrochloride 95% | 250mg | $540 | 2026-05-30 | Buy |
| Chemenu | CM261440 | 2-(trans-4-Aminocyclohexyl)-5-fluoroisoindolin-1-one hydrochloride 95%+ | 1g | $708 | 2026-05-26 | Buy |
| Crysdot | CD11237652 | 2-(trans-4-Aminocyclohexyl)-5-fluoroisoindolin-1-one hydrochloride 97% | 1g | $705 | 2026-05-26 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




